Related Experiment Videos
[New imaging methods by nuclear magnetic resonance in multiple sclerosis]
Abstract:
Magnetic resonance imaging (MRI) has rapidly attained a major position among the examinations used in the diagnostic approach of multiple sclerosis because it is highly sensitive in demonstrating lesions. However, these lesional images may have several meanings, and there is the problem of distinguishing between oedema, which is said to reflect recent lesions, and gliosis which is thought to betray old lesions. The intrinsic MRI parameters studied (i.e. relaxation times) are unable to make this distinction, whereas it is provided by paramagnetic contrast media such as gadolinium. There is no correlation between the changes observed at MRI and the severity of the disease. Another problem is the accuracy of lesion localization, since visualization is predominantly macroscopic. This raises several questions about the demonstration of correlations between clinical signs and site of the lesion(s). At the moment, several teams of neuroradiologists are trying to find the most reliable method to determine the size of the lesion. The possible prognostic value of this size and its changes as time goes by are other parameters to be considered once the basic diagnosis has been made.
Insights
Magnetic resonance imaging (MRI) is crucial for diagnosing multiple sclerosis (MS) by detecting lesions. Gadolinium contrast agents help differentiate recent (edema) from old (gliosis) lesions, improving diagnostic accuracy.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Context:
- Magnetic resonance imaging (MRI) is a primary tool for diagnosing multiple sclerosis (MS) due to its high sensitivity in visualizing lesions.
- Distinguishing between recent (edema) and old (gliosis) lesions is challenging using intrinsic MRI parameters alone.
- Current MRI visualization is largely macroscopic, limiting accurate lesion localization and correlation with clinical symptoms.
Purpose:
- To evaluate the utility of MRI in multiple sclerosis diagnosis.
- To explore methods for differentiating acute from chronic lesions in MS.
- To address challenges in lesion localization and size determination for prognostic value.
Summary:
- Intrinsic MRI relaxation times cannot distinguish between edema (recent lesions) and gliosis (old lesions) in MS.
- Paramagnetic contrast agents, like gadolinium, are necessary to differentiate lesion age.
- There is no established correlation between MRI findings and multiple sclerosis disease severity.
- Accurate lesion localization and size measurement remain significant challenges in MS imaging.
Impact:
- Gadolinium contrast agents enhance the diagnostic capability of MRI in multiple sclerosis by enabling differentiation of lesion activity.
- Improved lesion characterization and localization through advanced MRI techniques could lead to better correlation with clinical presentation.
- Further research into lesion size and its changes over time may provide valuable prognostic information for multiple sclerosis patients.